ProteinAggregationAndSubVisibleParticles_QualityChecker

Protein Aggregation And SubVisible Particles

Huvac human vaccines vaccination adjuvants mRNA vaccines sterility endotoxins cold chain

Utility description: Protein Aggregation And SubVisible Particles

Protein Aggregation And SubVisible Particles Quality Checker — Aggregate and Particle Control

ℹ️ Utility performs quality control of biopharmaceutical products, focusing on two critical safety aspects according to USP <787>, <788> and Ph. Eur.:
• Protein Aggregation: Quantitative assessment of High Molecular Weight (HMW) species formed during stress or storage.
• Subvisible Particles: Counting of insoluble particles sized 2-100 µm by MFI, LO or HIAC methods.
• Risk Assessment: Identification of potential immunogenicity (due to aggregates) and embolism risk (due to particles).

⚠️ IMPORTANT:
• Aggregates can act as adjuvants, triggering antibody production against the drug itself.
• Particles >10 µm can occlude capillaries.

Usage:
ProteinAggregationAndSubVisibleParticles_QualityChecker.exe → demo mode (console output)
ProteinAggregationAndSubVisibleParticles_QualityChecker.exe input.csv output.json → evaluate your data

Input format:
BatchNumber,ProductName,HMW_Percent,Max_HMW_Limit,Particles_GE_2um_per_mL,Limit_GE_2um_per_mL,Particles_GE_10um_per_mL,Limit_GE_10um_per_mL

Example:
BIO-001,mAb X,0.45,1.0,150,6000,12,600

📍 Scope of Application (Usage Where):
• Monoclonal Antibody Production: Quality control after purification and formulation.
• Stability Studies: Monitoring of aggregate formation during storage.
• Biosimilar Development: Comparative analysis with originator product.
• Regulatory Dossier: Preparation of impurity data for registration.

— WHY IS THIS NEEDED?
Protein products are prone to aggregation, which reduces their efficacy and safety.
Traditional microscopy does not see particles <100 µm, so specialized methods (MFI, SEC) are required.
Strict control of these parameters guarantees that patient receives safe and effective biopharmaceutical product.

⚠️ CRITICAL:
• HMW Limit: Usually strictly limited (<1-2%) due to ADA risk.
• Particle Counts: Must comply with USP <788> for small volumes (<100 mL).
• Detection Method: MFI is preferred for distinguishing protein aggregates from silicone droplets.
• Sample Handling: Avoid shaking that artificially creates aggregates.

Key features:
• Dual control of aggregates and particles
• Flexible limit adjustment for specific product
• Support for data from various analytical methods
• Report generation for LIMS integration
• Compliance with USP and Ph. Eur. requirements

Critical parameters:
• HMW Percent: < Spec Limit
• Particles ≥2µm: < Spec Limit
• Particles ≥10µm: < Spec Limit
• Method: Validated

💡 Usage tips:
1. Calibration: Use standard latex spheres for particle counter calibration.
2. Sample Prep: Gently mix sample avoiding foaming.
3. Background: Account for buffer background values during analysis.
4. Documentation: Save particle images (for MFI) as part of raw data.
5. Trends: Compare results with historical data to detect degradation.

⚠️ Note: This utility is a physicochemical and microscopic control tool. It does not replace functional activity tests but provides critical assessment of protein purity and safety.

input.csv

BatchNumber,ProductName,HMW_Percent,Max_HMW_Limit,Particles_GE_2um_per_mL,Limit_GE_2um_per_mL,Particles_GE_10um_per_mL,Limit_GE_10um_per_mL
BIO-2026-MAB-001,Adalimumab Biosimilar,0.45,1.0,150,6000,12,600
BIO-2026-MAB-002,Trastuzumab,2.5,1.0,4500,6000,400,600
BIO-2026-MAB-003,Rituximab,0.15,0.5,80,6000,5,600

URS & FS — User Requirements and Functional Specification

This document describes the controlled interface and behaviour of ProteinAggregationAndSubVisibleParticles_QualityChecker for Protein Aggregation And SubVisible Particles Quality Checker.

Domain limits URS input.csv FS IQ/OQ/PQ

Domain limits and critical parameters

Key fragments from the source description are shown below. Before production use, limits must be verified against the approved specification, registration dossier and local SOPs.

ℹ️ Utility performs quality control of biopharmaceutical products, focusing on two critical safety aspects according to USP <787>, <788> and Ph. Eur.:
• Particles >10 µm can occlude capillaries.
BatchNumber,ProductName,HMW_Percent,Max_HMW_Limit,Particles_GE_2um_per_mL,Limit_GE_2um_per_mL,Particles_GE_10um_per_mL,Limit_GE_10um_per_mL
• Regulatory Dossier: Preparation of impurity data for registration.
Protein products are prone to aggregation, which reduces their efficacy and safety.
Traditional microscopy does not see particles <100 µm, so specialized methods (MFI, SEC) are required.
⚠️ CRITICAL:
• HMW Limit: Usually strictly limited (<1-2%) due to ADA risk.
• Particle Counts: Must comply with USP <788> for small volumes (<100 mL).
• Flexible limit adjustment for specific product
• Compliance with USP and Ph. Eur. requirements
Critical parameters:
• HMW Percent: < Spec Limit
• Particles ≥2µm: < Spec Limit
• Particles ≥10µm: < Spec Limit
⚠️ Note: This utility is a physicochemical and microscopic control tool. It does not replace functional activity tests but provides critical assessment of protein purity and safety.

URS — User Requirements Specification

ID	Requirement	Criticality	Acceptance criterion
URS-001	The utility shall accept an input.csv file for Protein Aggregation And SubVisible Particles Quality Checker with headers defined in the data contract.	High	The file is processed without manual header editing.
URS-002	The utility shall perform deterministic QC evaluation without machine learning and without probabilistic conformance decisions.	High	Identical input data, rule version and configuration produce reproducible results.
URS-003	The utility shall validate mandatory fields, data types, ranges, units and domain plausibility.	High	Schema, conversion and range errors are explicitly reported.
URS-004	The utility shall apply domain limits and rules from the description, approved specification, registration dossier and local SOPs.	High	Each check has PASS/WARNING/FAIL and a clear message.
URS-005	The utility shall generate output.json with machine-readable results, source values, warnings, failures and critical findings.	High	JSON is suitable for LIMS/ELN/MES integration and QA/QC review.
URS-006	The utility shall preserve traceability between batch/sample, input file, applied rules and final status.	High	Output contains identifiers, checked parameters and audit metadata.
URS-007	The documentation shall support IQ/OQ/PQ, CSV/CSA and review by internal QA or inspectors.	Medium	URS, FS, input/output contract and test scenarios are supplied with the utility.
URS-008	The utility shall be used as a QC decision-support tool and not as a substitute for approved specifications and QA/QP release decision.	Medium	Documentation states change control and limit-verification expectations.

input.csv contract

#	Field	Type	Sample	Purpose
1	`BatchNumber`	string / controlled vocabulary	`BIO-2026-MAB-001`	Batch or lot identifier used for traceability.
2	`ProductName`	string / controlled vocabulary	`Adalimumab Biosimilar`	Product or dosage-form name under evaluation.
3	`HMW_Percent`	decimal	`0.45`	Controlled input parameter for deterministic QC rules.
4	`Max_HMW_Limit`	decimal	`1.0`	Approved limit applied during result evaluation.
5	`Particles_GE_2um_per_mL`	decimal	`150`	Volume/dose used for load, limit or release calculation.
6	`Limit_GE_2um_per_mL`	decimal	`6000`	Volume/dose used for load, limit or release calculation.
7	`Particles_GE_10um_per_mL`	decimal	`12`	Volume/dose used for load, limit or release calculation.
8	`Limit_GE_10um_per_mL`	decimal	`600`	Volume/dose used for load, limit or release calculation.

BatchNumber,ProductName,HMW_Percent,Max_HMW_Limit,Particles_GE_2um_per_mL,Limit_GE_2um_per_mL,Particles_GE_10um_per_mL,Limit_GE_10um_per_mL
BIO-2026-MAB-001,Adalimumab Biosimilar,0.45,1.0,150,6000,12,600
BIO-2026-MAB-002,Trastuzumab,2.5,1.0,4500,6000,400,600
BIO-2026-MAB-003,Rituximab,0.15,0.5,80,6000,5,600

Input validation rules

ID	Field	Rule	Criticality
VR-001	`BatchNumber`	The field shall match an approved dictionary or accepted string representation.	High
VR-002	`ProductName`	The field shall match an approved dictionary or accepted string representation.	High
VR-003	`HMW_Percent`	The field shall match an approved dictionary or accepted string representation.	High
VR-004	`Max_HMW_Limit`	The field shall match an approved dictionary or accepted string representation.	Medium
VR-005	`Particles_GE_2um_per_mL`	The field shall match an approved dictionary or accepted string representation.	Medium
VR-006	`Limit_GE_2um_per_mL`	The field shall match an approved dictionary or accepted string representation.	Medium
VR-007	`Particles_GE_10um_per_mL`	The field shall match an approved dictionary or accepted string representation.	Medium
VR-008	`Limit_GE_10um_per_mL`	The field shall match an approved dictionary or accepted string representation.	Medium

FS — Functional Specification

ID	Function	Implementation
FS-001	CLI execution	Support execution modes: demo mode without arguments and production mode input.csv output.json.
FS-002	CSV import	Read input.csv in UTF-8/CSV-compatible format and validate header and expected columns.
FS-003	Schema validation	Check mandatory fields, column count, unknown key fields and empty mandatory values.
FS-004	Type conversion	Convert numeric, flag and text values; invalid format is recorded as a row-level error.
FS-005	Domain rule engine	Apply rules for Protein Aggregation And SubVisible Particles Quality Checker, including critical limits from the description and approved specification.
FS-006	Status aggregation	Produce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance.
FS-007	JSON export	Write output.json with detailed checks, source values, warnings, failures and critical findings.
FS-008	Audit support	Keep result structure suitable for review, deviation investigation and calculation reproduction.
FS-009	Integration contract	Support the scenario LIMS/ELN/MES → input.csv → utility → output.json → portal/admin review.
FS-010	Error handling	Return explicit messages for missing file, empty CSV, invalid schema, output write failure and invalid format.

Example output.json

{
  "utilityId": "proteinaggregationandsubvisibleparticles-qualitychecker",
  "utilityFolder": "ProteinAggregationAndSubVisibleParticles_QualityChecker",
  "package": "huvac",
  "overallStatus": "PASS|WARNING|FAIL",
  "sourceFile": "input.csv",
  "processedAtUtc": "2026-06-10T00:00:00Z",
  "checks": [
    {
      "parameter": "BatchNumber",
      "value": "BIO-2026-MAB-001",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-001"
    },
    {
      "parameter": "ProductName",
      "value": "Adalimumab Biosimilar",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-002"
    },
    {
      "parameter": "HMW_Percent",
      "value": "0.45",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-003"
    },
    {
      "parameter": "Max_HMW_Limit",
      "value": "1.0",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-004"
    },
    {
      "parameter": "Particles_GE_2um_per_mL",
      "value": "150",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-005"
    },
    {
      "parameter": "Limit_GE_2um_per_mL",
      "value": "6000",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-006"
    },
    {
      "parameter": "Particles_GE_10um_per_mL",
      "value": "12",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-007"
    },
    {
      "parameter": "Limit_GE_10um_per_mL",
      "value": "600",
      "status": "PASS|WARNING|FAIL",
      "message": "Deterministic rule-based check result",
      "ruleReference": "FS-RULE-008"
    }
  ],
  "criticalFindings": [],
  "warnings": [],
  "audit": {
    "inputHash": "sha256:<calculated at runtime>",
    "rulesVersion": "<utility executable version>",
    "documentation": "ProteinAggregationAndSubVisibleParticles_QualityChecker.documentation.html"
  }
}

Traceability matrix

URS	FS	Test	Evidence
URS-001	FS-001, FS-002	OQ-001	Verify execution and import of valid input.csv.
URS-002	FS-005, FS-006	OQ-004	Repeat the same dataset and compare output.json.
URS-003	FS-003, FS-004, FS-010	OQ-002, OQ-003	Verify missing columns and invalid types.
URS-004	FS-005, FS-006	OQ-004, PQ-001	Verify critical deviations on real/boundary data.
URS-005	FS-007, FS-009	OQ-005	Verify JSON schema and downstream-system suitability.
URS-006	FS-008	OQ-006	Verify identifiers and audit metadata.
URS-007	FS-008, FS-010	IQ-001, OQ-007	Verify documentation completeness and control evidence.
URS-008	FS-005, FS-008	PQ-002	Verify review workflow and no replacement of QA decision.

IQ/OQ/PQ test scenarios

ID	Scenario	Expected result
IQ-001	Verify executable, input.csv, documentation and checksum availability.	Delivery set is complete; version is recorded.
OQ-001	Valid sample row from input.csv.	PASS or acceptable WARNING according to rules.
OQ-002	Remove a mandatory CSV column.	Schema error or FAIL with missing-column reference.
OQ-003	Place a non-numeric value into a numeric field.	Type-conversion error with row/field reference.
OQ-004	Set a critical parameter outside the limit.	FAIL and critical finding.
OQ-005	Verify output.json structure.	All mandatory sections are present and JSON is valid.
OQ-006	Verify batch/sample traceability.	Input and result identifiers match.
PQ-001	Verify 3–5 real user batches/samples.	Result is confirmed by QC/QA review.
PQ-002	Verify deviation workflow and manual QA decision.	Utility supports review but does not replace approved decision.

QA/QC and change control

Do not rename columns without updating validator, documentation and test set.
Retain input.csv, output.json, executable version and checksum.
Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
Critical limits shall be verified against the approved specification, registration dossier and local SOPs.
The utility provides structured QC decision support; final release decision remains with QA/QP and approved procedures.

Included in packages

Biopharmaceuticals Extended QC Suite

Extended QC utility coverage for mAbs, biosimilars, proteins, insulins, vaccines, mRNA/LNP, HCP, sterile release, microbiology, water, cleanroom and stability workflows.

Open

Huvac — Human Vaccine QC Utilities

Huvac contains QC utilities for human vaccines: adjuvants, antigen potency, sterility, endotoxins, cold chain, mRNA controls, container closure and stability checks.

Open

Immunology QC Suite

QC utility package for immunology: monoclonal antibodies, biosimilars, immunomodulators, immunosuppressants, ELISA/SPR, HCP, protein characterization, sterility and pyrogen/release checks.

Open